Device |
levetiracetam assay |
Regulation Description |
Diphenylhydantoin test system. |
Definition |
For the quantitative determination of levetiracetam in human serum or plasma. |
Physical State |
measurement of anit-seizure medication |
Technical Method |
immunoassay |
Target Area |
in vitro diagnostic |
Regulation Medical Specialty |
Toxicology |
Review Panel |
Toxicology |
Product Code | ORI |
Premarket Review |
Division of Chemistry and Toxicology Devices
(DCTD)
Division of Chemistry and Toxicology Devices
(DCTD)
|
Submission Type |
510(k)
|
Regulation Number |
862.3350
|
Device Class |
2
|
Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
GMP Exempt? |
No
|
Summary Malfunction Reporting |
Eligible |
Implanted Device? |
No
|
Life-Sustain/Support Device? |
No
|
Third Party Review
|
Accredited Persons
|